DOI: https://doi.org/10.24959/nphj.18.2183

The effect of derivatives of sulfur-containing amino acids (ademetionine, taurine and glutathione) on survival of animals with acute kidney injury of various genesis

V. M. Drachuk, I. I. Zamorskii, T. S. Shchudrova, Ol. M. Goroshko

Abstract


Aim. To study the nephroprotective effect of sulfur-containing amino acids (ademetionine, taurine and glutathione) on different models of acute kidney injury (AKI) by the integral index of the survival rate of animals.

Materials and methods. The experiments were performed on 105 non-linear mature white laboratory rats and 35 mice. The drugs studied – ademetionine (Geptral, Abbott SpA, Italy) in the dose of 20 mg/kg, glutathione (TAD 600, Biomedica Foscama, Italy) in the dose of 30 mg/kg and taurine (Sigma-Aldrich, USA) in the dose of dose 100 mg/kg – were injected intraperitoneally 3-7 days before AKI modeling. Rhabdomyolysis-induced AKI was modeled by the intramuscular injection of 50 % glycerol solution in the dose of 10 ml/kg, toxic AKI – by the injection of gentamicin solution in the dose of 80 mg/kg and the subcutaneous injection of ethylene glycol in the dose of 10 ml/kg. Simulation of renal ischemia was performed under general anesthesia (ethaminal sodium, 40 mg/kg) by clamping of both renal pedicles for a period of 60 min, followed by reperfusion for 24 h.

Results and discusion. The experimental results show a significant improvement in the survival of animals under the effect of the drugs of derivatives of sulfur-containing amino acids studied in conditions of various models of AKI. Ademetionine, taurine and glutathione reduced the lethality of animals on models of rhabdomyolytic, gentamicin, ischemia-reperfusion AKI. In conditions of ethylene glycol intoxication the highest nephroprotective activity by the survival criterion was shown by glutathione (57.1 % survival at 48 h after administration of ethylene glycol against 100 % of mortality in the control group (p < 0.05).

Conclusions. All derivatives of sulfur-containing amino acids studied (ademetionine, taurine and glutathione) exhibit the nephroprotective activity by the criterion of survival of animals on various models of AKI. Glutathione demonstrates the best survival of animals with acute kidney injury of various genesis, while ademetionine has the lowest survival.


Keywords


nephroprotection; acute kidney injury; survival; ademetionine; taurine; glutathione

Full Text:

PDF

References


Waikar, S. S., Liu, K. D., & Chertow, G. M. (2008). Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury. Clinical Journal

of the American Society of Nephrology, 3 (3), 844–861. https://doi.org/10.2215/cjn.05191107

Semidotska, Z. D., Chernyakova, I. A., Pionova, O. M., … Tryfonova, N. S. (2017). Acute kidney injury: modern view of problem.

Shidnoevropejskij Zurnal Vnutrisnoi Ta Simejnoi Medicini, 2017 (1), 10–16. https://doi.org/10.15407/internalmed2017.01.010

Acute kidney injury: Current concepts and new insights. (2014). Journal of Injury and Violence Research, 8 (1), 58–62. https://doi.

org/10.5249/jivr.v8i1.610

Kellum, J. A., & Lameire, N. (2013). Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Critical

Care, 17 (1), 204. https://doi.org/10.1186/cc11454

Song, C. H., Bae, H. J., Ham, Y. R., Na, K. R., Lee, K. W., & Choi, D. E. (2017). A Case of Ethylene Glycol intoxication with Acute

Renal Injury: Successful Recovery by Fomepizole and Renal Replacement Therapy. Electrolytes & Blood Pressure, 15 (2), 47. https://

doi.org/10.5049/ebp.2017.15.2.47

Gardner, T. B., Manning, H. L., Beelen, A. P., Cimis, R. J., Cates, J. M., Lewis, L. D. (2004). Ethylene glycol toxicity associated with

ischemia, perforation, and colonic oxalate crystal deposition. J. Clin. Gastroenterol, 38, 435–439.

Rahman, S. S., Kadakia, S., Balsam, L., & Rubinstein, S. (2011). Autonomic Dysfunction as a Delayed Sequelae of Acute Ethylene

Glycol Ingestion. Journal of Medical Toxicology, 8 (2), 124–129. https://doi.org/10.1007/s13181-011-0195-x

Hanouneh, M., & Chen, T. K. (2017). Calcium Oxalate Crystals in Ethylene Glycol Toxicity. New England Journal of Medicine, 377 (15),

https://doi.org/10.1056/nejmicm1704369

Liberek, T., Śliwarska, J., Czurak, K., Perkowska-Ptasińska, A., Weber, E., Rutkowski, B. (2013). Prolonged renal failure in the course

of atypical ethylene glycol intoxication. Acta Biochimica Polonica, 4 (60), 661–663.

Zviahyntseva, T. D., Chernobai, A. Y., Hlushchenko, S. V. (2014). Ukrainskyi medychnyi chasopys, 3 (101), 56–59.

Anstee, Q. M., & Day, C. P. (2012). S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical

utility. Journal of Hepatology, 57 (5), 1097–1109. https://doi.org/10.1016/j.jhep.2012.04.041

Ostapiv, R. D., Kystsiv, O. S., Manko, V. V. (2015). Visnyk Lvivskoho universytetu. Seriia Biolohichna, 69, 247–255.

Shimada, K., Jong, C. J., Takahashi, K., & Schaffer, S. W. (2015). Role of ROS Production and Turnover in the Antioxidant Activity of

Taurine. Advances in Experimental Medicine and Biology, 581–596. https://doi.org/10.1007/978-3-319-15126-7_47

Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., … Domenicotti, C. (2013). Role of Glutathione in

Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity, 2013, 1–10. https://doi.org/10.1155/2013/972913

Salyha, N. O. (2013). Ukraïns’kij bìofarmacevtičnij žurnal, 85 (4), 40–47.

Horoshko, O. M., Zamorskyi, I. I. (2008). Vìsnik farmacìï, 1 (53), 67–71.

Martynjuk, L. P., Ruzhickaja, O. A., Martynjuk, E. S. (2015). Pochki, 1, 24–32.

Arakelian, N. H., Shtryhol, S. Yu. (2006). Ukraine. Patent No 28140. Patent and Trademark Office.

Shtryhol, S. Yu., Lisovyi, V. M., Zupanets, I. A. (2009). Metody eksperymentalnoho modeliuvannia urazhennia nyrok pry farmakolohichnykh

doslidzhenniakh: Metodychni rekomendatsii DFTs Ukrainy. Kyiv, 9–10.

Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes. (2010).

Official Journal of the European Union, 53 (276), 33–80.


GOST Style Citations


1. Diagnosis, epidemiology and outcomes of acute kidney injury / S. S. Waikar, K. D. Lin, J. M. Chertow et al. // Soc. Nephrol. – 2008. –
№ 3 (3). – Р. 844–861. https://doi.org/10.2215/cjn.05191107

2. Острое повреждение почек : современный взгляд на проблему / Ж. Д. Семидоцкая, И. А. Чернякова, Е. Н. Пионова и др. //
Східноєвропейський журн. внутрішньої та сімейної медицини. – 2017. – № 1. – С. 10–16. https://doi.org/10.15407/internalmed2017.01.010

3. Koza, Ya. J. Acute kidney injury : current concepts and new insights / Ya. Koza J. // Inj. Violence Res. – 2016. – № 8 (1). – Р. 58–62.
https://doi.org/10.5249/jivr.v8i1.610

4. Diagnosis, evaluation, and management of acute kidney injury : a KDIGO summary (Part 1). Crit Care / J. A. Kellum, N. Lameire, for
the KDIGO AKI Guideline Work Group. – 2013. – № 17 (1). – Р. 204. https://doi.org/10.1186/cc11454

5. A Case of Ethylene Glycol intoxication with Acute Renal Injury: Successful Recovery by Fomepizole and Renal Replacement Therapy /
Н. S. Chang, J. B. Hong, R. H. Young et al. // Electrolyte Blood Press. – 2017. – № 15 (2). – Р. 47–51. https://doi.org/10.5049/
ebp.2017.15.2.47

6. Ethylene glycol toxicity associated with ischemia, perforation, and colonic oxalate crystal deposition / T. B. Gardner, H. L. Manning,
A. P. Beelen et al. // J. Clin. Gastroenterol. – 2004. – № 38. – Р. 435–439.

7. Autonomic Dysfunction as a Delayed Sequelae of Acute Ethylene Glycol Ingestion / S. S. Rahman, S. Kadakia, L. Balsam et al. // Med.
Toxicol. – 2012. – № 8. – Р. 124–129. https://doi.org/10.1007/s13181-011-0195-x

8. Hanouneh, M. Calcium Oxalate Crystals in Ethylene Glycol Toxicity / M. Hanouneh, T. K. Chen // New Engl. J. Med. – 2017. – № 377.
– P. 1467. https://doi.org/10.1056/nejmicm1704369

9. Prolonged renal failure in the course of atypical ethylene glycol intoxication / T. Liberek, J. Śliwarska, K. Czurak et al. // Acta Biochimica
Polonica. – 2013. – № 4 (60). – P. 661–663.

10. Звягинцева, Т. Д. Роль адеметионина в развитии и прогрессировании хронических заболеваний печени / Т. Д. Звягинцева, А. И. Чернобай, С. В. Глущенко // Укр. мед. часопис. – 2014. – № 3 (101). – C. 56–59.

11. Anstee, Q. M. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility / Q. M. Anstee,
C. P. Day // J. Hepatol. – 2012. – № 57. – P. 1097–1109. https://doi.org/10.1016/j.jhep.2012.04.041

12. Остапів, Р. Д. Вплив таурину на фізіологічні показники щурів / Р. Д. Остапів, О. С. Кисців, В. В. Манько // Вісник Львів. ун-ту.
Сер. Біол. – 2015. – № 69. – С. 247–255.

13. Role of ROS production and turnover in the antioхidant activity of taurine / K. Shimada, C. J. Jong, K. Takahashi, S. W. Schaffer // Adv.
Exp. Med. Biol. – 2015. – № 803. – Р. 581–596. https://doi.org/10.1007/978-3-319-15126-7_47

14. Role of Glutathione in Cancer Progression and Chemoresistanc / N. Traverso, R. Ricciarelli, M. Nitti et al. // Oxid. Med. Cell Longev. –
2013. – Vol. 2013. – Р. 1–10. https://doi.org/10.1155/2013/972913

15. Салига, Н. О. Активність глутатіонової системи антиоксидантного захисту в щурів за дії L-глутамінової кислоти / Н. О. Салига //
Укр. біохім. журн. – 2013. – № 85 (4). – С. 40–47.

16. Горошко, О. М. Лікувальна ефективність одноразового введення ліпосомального препарату кверцетину «Ліпофлавон» при експриментальній гострій нирковій недостатності / О. М. Горошко, І. І. Заморський // Вісник фармації. – 2008. – № 1 (53). – С. 67–71.

17. Мартынюк, Л. П. Влияние растительного препарата Канефрон H на течение диабетической нефропатии у пациентов с сахарным диабетом 2-го типа: результаты сравнительного когортного исследования / Л. П. Мартынюк, О. А. Ружицкая, Е. С. Марты-
нюк // Почки. – 2015. – № 1. – С. 24–32.

18. Пат. 28140 Україна, МПК (2006) А 61 К 31/4425. Застoсування мексидoлу як нефрoпрoтектoрнoгo засoбу / Аракелян Н. Г.,
Штригoль С. Ю. ; заявник та патентoвласник Націoнальний фармацевтичний університет. u200708435; заявл.: 23.07.2007 ;
oпубл.: 26.11.2007. – Бюл. № 19. – 4 c.

19. Методи експериментального моделювання ураження нирок при фармакологічних дослідженнях: метод. рек. ДФЦ України /
С. Ю. Штриголь, В. М. Лісовий, І. А. Зупанець та ін. – К., 2009. – С. 9–10.

20. Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes // Official
J. of the Eur. Union. – 2010. – Vol. 53, Issue 276. – P. 33–80.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Vìsn. farm.

ISSN 2415-8844 (Online), ISSN 1562-7241 (Print)